Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in

  News Archive

Flesh-Eating Bacteria Work Together
Wednesday, January 27, 2016
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.

Utilizing Antibodies from Ebola Survivors
Wednesday, January 27, 2016
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.

Antibiotic Use in Early Life Disrupts Gut Microbiota
Wednesday, January 27, 2016
The use of antibiotics in early childhood interferes with normal development of the intestinal microbiota, shows research conducted at the University of Helsinki.

MorphoSys Announces Clinical Milestone for Start of Bayer's Phase 2 Trial
Wednesday, January 27, 2016
Phase 2 trial designed to support registration of anetumab ravtansine.

SCIEX, A*STAR’s BTI Launch Collaboration
Wednesday, January 27, 2016
Agreement aims to boost innovation of protein drugs that target new diseases and are safer for patients.

Easier Diagnosis for Fungal Infection of the Lungs
Tuesday, January 26, 2016
A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner and more effectively.

UCL Launches £50 million Technology Investment Fund
Monday, January 25, 2016
UCL is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research emerging over the next five years.

Mitochondrial Troublemakers Unmasked in Lupus
Monday, January 25, 2016
Drivers of autoimmune disease inflammation discovered in the traps of pathogen-capturing white blood cells.

MD Anderson, AbbVie Collaborate
Monday, January 25, 2016
The immunotherapy platform at The University of Texas MD Anderson Cancer Center and the global biopharmaceutical company AbbVie will join forces to find new ways to unleash the immune system’s potential to fight cancer.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 1717

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos